Annual Total Liabilities
$130.60 M
-$24.09 M-15.57%
31 December 2023
Summary:
Allogene Therapeutics annual total liabilities is currently $130.60 million, with the most recent change of -$24.09 million (-15.57%) on 31 December 2023. During the last 3 years, it has fallen by -$17.61 million (-11.88%). ALLO annual total liabilities is now -15.57% below its all-time high of $154.70 million, reached on 31 December 2022.ALLO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$125.37 M
-$6.47 M-4.91%
30 September 2024
Summary:
Allogene Therapeutics quarterly total liabilities is currently $125.37 million, with the most recent change of -$6.47 million (-4.91%) on 30 September 2024. Over the past year, it has dropped by -$3.85 million (-2.98%). ALLO quarterly total liabilities is now -79.23% below its all-time high of $603.68 million, reached on 30 September 2018.ALLO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.6% | -3.0% |
| 3 y3 years | -11.9% | +14.7% |
| 5 y5 years | +84.8% | +65.3% |
ALLO Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -15.6% | +4.0% | -19.0% | +14.7% |
| 5 y | 5 years | -15.6% | +84.8% | -19.0% | +65.3% |
| alltime | all time | -15.6% | >+9999.0% | -79.2% | +627.5% |
Allogene Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $125.37 M(-4.9%) |
| June 2024 | - | $131.84 M(+5.5%) |
| Mar 2024 | - | $124.98 M(-4.3%) |
| Dec 2023 | $130.60 M(-15.6%) | $130.60 M(+1.1%) |
| Sept 2023 | - | $129.22 M(-12.7%) |
| June 2023 | - | $148.06 M(-4.2%) |
| Mar 2023 | - | $154.61 M(-0.1%) |
| Dec 2022 | $154.70 M(+23.1%) | $154.70 M(+4.8%) |
| Sept 2022 | - | $147.61 M(+1.3%) |
| June 2022 | - | $145.69 M(+33.2%) |
| Mar 2022 | - | $109.40 M(-12.9%) |
| Dec 2021 | $125.63 M | $125.63 M(+14.9%) |
| Sept 2021 | - | $109.30 M(+6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $102.91 M(-5.8%) |
| Mar 2021 | - | $109.27 M(-26.3%) |
| Dec 2020 | $148.21 M(+66.9%) | $148.21 M(+42.8%) |
| Sept 2020 | - | $103.77 M(+9.1%) |
| June 2020 | - | $95.13 M(+16.0%) |
| Mar 2020 | - | $82.00 M(-7.6%) |
| Dec 2019 | $88.78 M(+25.6%) | $88.78 M(+17.1%) |
| Sept 2019 | - | $75.83 M(-3.2%) |
| June 2019 | - | $78.36 M(+15.0%) |
| Mar 2019 | - | $68.14 M(-3.6%) |
| Dec 2018 | $70.69 M(>+9900.0%) | $70.69 M(-88.3%) |
| Sept 2018 | - | $603.68 M(+3403.0%) |
| June 2018 | - | $17.23 M |
| Dec 2017 | $2000.00 | - |
FAQ
- What is Allogene Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Allogene Therapeutics?
- What is Allogene Therapeutics annual total liabilities year-on-year change?
- What is Allogene Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly total liabilities year-on-year change?
What is Allogene Therapeutics annual total liabilities?
The current annual total liabilities of ALLO is $130.60 M
What is the all time high annual total liabilities for Allogene Therapeutics?
Allogene Therapeutics all-time high annual total liabilities is $154.70 M
What is Allogene Therapeutics annual total liabilities year-on-year change?
Over the past year, ALLO annual total liabilities has changed by -$24.09 M (-15.57%)
What is Allogene Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ALLO is $125.37 M
What is the all time high quarterly total liabilities for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly total liabilities is $603.68 M
What is Allogene Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ALLO quarterly total liabilities has changed by -$3.85 M (-2.98%)